Afya (NASDAQ:AFYA) Stock Price Down 4.9% – What’s Next?

Posted by Geri Gentry on Sep 25th, 2026

Afya Limited (NASDAQ:AFYA – Get Free Report)’s stock price fell 4.9% on Friday. The stock traded as low as $13.15 and last traded at $13.06. 53,162 shares changed hands during trading, a decline of 59% from the average daily volume of 130,384 shares. The stock had previously closed at $13.73.

Key Afya News

Here are the key news stories impacting Afya this week:

Positive Sentiment: Merger creates a substantially larger education platform. Afya and Yduqs signed a binding agreement to combine their Brazilian higher-education operations, creating a group with approximately 1.6 million students and R$9.4 billion in revenue. Afya shareholders are expected to own about 69.3% of the combined company. Afya and Yduqs merger agreement
Positive Sentiment: Potential for synergies and stronger cash generation. Management commentary and analyst scenarios point to accelerated cash-flow generation, further consolidation opportunities and potentially significant operating synergies. The agreement also reportedly contemplates approximately R$750 million in dividends. JPMorgan merger scenarios
Neutral Sentiment: Analyst valuation remains above the recent trading level. Afya has a consensus target price of $17.75, suggesting analysts see potential upside, although the target may not yet reflect the final merger structure or transaction risks. Afya consensus target price
Negative Sentiment: Short interest increased sharply. Reported short interest as of September 15 reached 1.41 million shares, up 163.2% from August 31, with 5.2 days to cover. This indicates that some traders are positioning for further weakness, although the data conflicts with a separate report showing zero short interest. Afya short-interest data
Negative Sentiment: Investors face transaction uncertainty. Reports indicate the deal could eventually remove AFYA from Nasdaq while maintaining Yduqs’ B3 listing. Integration costs, regulatory approvals, the final share-exchange terms and possible dilution may be weighing on the stock. Zacks also placed AFYA on its Rank #5 “Strong Sell” list. Potential Nasdaq delisting report

Wall Street Analyst Weigh In

Several brokerages have recently commented on AFYA. Weiss Ratings downgraded shares of Afya from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, July 31st. Zacks Research downgraded shares of Afya from a “hold” rating to a “strong sell” rating in a report on Friday, August 21st. JPMorgan Chase & Co. cut their price target on Afya from $21.50 to $21.00 and set a “neutral” rating for the company in a research note on Monday, June 22nd. Bank of America reissued a “neutral” rating on shares of Afya in a report on Thursday, June 11th. Finally, Bradesco Corretora upgraded Afya to an “outperform” rating and set a $17.00 price objective on the stock in a research report on Thursday. One research analyst has rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $17.75.

Check Out Our Latest Research Report on AFYA

Afya Trading Down 5.3%

The company has a debt-to-equity ratio of 0.39, a current ratio of 2.20 and a quick ratio of 2.20. The stock’s 50-day moving average is $14.01 and its two-hundred day moving average is $14.34. The stock has a market cap of $1.22 billion, a P/E ratio of 7.94, a price-to-earnings-growth ratio of 1.51 and a beta of 0.35.

Afya (NASDAQ:AFYA – Get Free Report) last posted its earnings results on Friday, August 14th. The company reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.03. The company had revenue of $187.80 million during the quarter, compared to analysts’ expectations of $189.62 million. Afya had a net margin of 20.55% and a return on equity of 17.58%. Equities research analysts anticipate that Afya Limited will post 1.86 EPS for the current year.

Insider Buying and Selling at Afya

In other news, VP Lélio de Souza, Jr. sold 36,204 shares of Afya stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $15.00, for a total value of $543,060.00. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.80% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Afya

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AFYA. Engineers Gate Manager LP bought a new position in Afya in the 2nd quarter worth about $325,000. Public Employees Retirement System of Ohio bought a new stake in shares of Afya during the second quarter valued at approximately $67,000. Banco BTG Pactual S.A. bought a new stake in shares of Afya during the fourth quarter valued at approximately $462,000. Finally, Swedbank AB boosted its holdings in shares of Afya by 170.3% in the fourth quarter. Swedbank AB now owns 189,200 shares of the company’s stock valued at $2,916,000 after purchasing an additional 119,200 shares during the period. 88.02% of the stock is owned by institutional investors.

Afya Company Profile

(Get Free Report)

Afya Limited is a Brazilian medical education and technology company that operates an integrated platform for physicians and medical students. The company provides education and professional development throughout the medical career cycle, from undergraduate training and residency preparation to continuing medical education and specialization programs.

Afya’s offerings include medical schools, preparatory courses, postgraduate and continuing education programs, digital learning tools, and clinical practice technologies.